Abstract
The past year has seen some extraordinary activity in clinical amyotrophic lateral sclerosis (ALS) research. Two trials were completed, with negative results, but the discovery of novel ALS-associated genes, and body fluid and imaging biomarkers warrants cautious optimism. Here, we provide a snapshot of some of the main findings in 2014.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Amyotrophic Lateral Sclerosis / diagnosis*
-
Amyotrophic Lateral Sclerosis / drug therapy*
-
Amyotrophic Lateral Sclerosis / genetics
-
Amyotrophic Lateral Sclerosis / metabolism*
-
Biomarkers / metabolism*
-
Clinical Trials as Topic
-
Humans
-
Research